Travere Therapeutics (TVTX) PT Raised to $19 at BofA Securities
Tweet Send to a Friend
BofA Securities analyst Greg Harrison raised the price target on Travere Therapeutics (NASDAQ: TVTX) to $19.00 (from $18.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
